Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
NCT01473524
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Biliary Cirrhosis
Interventions
DRUG:
Obeticholic Acid (OCA)
DRUG:
Placebo
Sponsor
Intercept Pharmaceuticals